Posted by Michael Wonder on 12 Aug 2025
New and expanded PBS listings for endometrial cancer, neuroblastoma, Parkinson's disease and melanoma
11 August 2025 - Australians with Parkinson’s disease, neuroblastoma, endometrial cancer, cystic fibrosis and melanoma will have access to new and expanded medicines under the PBS from 1 August 2025.
Foslevodopa with Foscarbidopa (Vyalev) will be listed for the first time to treat advanced Parkinson’s disease with severe disabling motor fluctuations not adequately controlled by oral therapy.
